Skip to main content

Table 4 Risk factors for lost to follow-up and transfer-out combined among foreign-born LTBI patients

From: Trend and treatment outcomes of latent tuberculosis infection among migrant persons in Japan: retrospective analysis of Japan tuberculosis surveillance data

 

Crude OR

95% CI

Adjusted OR

95% CI

P

Sex

 Male

Reference

 Female

1.08

0.78–1.49

1.16

0.81–1.66

0.41

Age groups (age groups)

 0–14

Reference

 15–19

0.79

0.21–2.88

2.02

0.20–20.39

0.55

 20–29

1.06

0.41–2.78

3.06

0.24–38.79

0.39

 30–39

1.58

0.60–4.20

5.50

0.42–71.34

0.19

 40–49

1.41

0.51–3.88

5.01

0.37–67.1

0.22

 50 plus

1.02

0.35–2.94

3.58

0.26–49.37

0.34

Job status

 Healthcare workers (HCW)

Reference

 Full-time work, other than HCW

1.17

0.58–2.39

1.29

0.60–2.76

0.51

 Self-employed

1.18

0.24–5.84

1.21

0.23–6.39

0.82

 Employed on daily/temporal basis

2.67

1.21–5.88

3.11

1.34–7.26

< 0.05

 Houseworkers

1.43

0.28–7.20

1.12

0.21–5.89

0.89

 Students, high school and above

1.22

0.60–2.50

1.98

0.85–4.64

0.11

 Secondary, primary school students, other children and infants

1.25

0.43–3.64

4.97

0.42–58.75

0.20

 Unemployed

1.05

0.40–2.79

1.07

0.35–3.26

0.90

 Others and unknown

3.14

1.33–7.41

4.09

1.60–10.48

< 0.05

Country of Birth

 Others

Reference

 the Philippines

1.17

0.72–1.88

1.05

0.63–1.77

0.84

 China

0.99

0.59–1.65

0.92

0.54–1.57

0.75

 Vietnam

1.17

0.68–2.00

1.38

0.76–2.49

0.29

 Nepal

0.70

0.38–1.29

0.64

0.33–1.24

0.18

 Indonesia

0.87

0.37–2.05

1.19

0.48–2.97

0.71

Regimen

 RFP monotherapy

Reference

 INH monotherapy

2.05

0.82–5.14

2.14

0.82–5.54

0.12

 Other

4.87

0.43–55.7

4.57

0.29–71.53

0.28

Health insurance

 National health insurance

Reference

 Social welfare

1.49

0.43–5.22

1.85

0.45–7.61

0.39

 Others and unknown

1.32

0.64–2.73

1.13

0.53–2.43

0.76

Modes of detection

 Contact investigation

Reference

 Routine screening

0.94

0.49–1.80

1.09

0.54–2.21

0.80

 At hospital

1.10

0.63–1.92

1.17

0.63–2.17

0.63

 Other mass screening

0.26

0.03–1.89

0.19

0.02–1.47

0.11

 Others

0.68

0.24–1.93

0.64

0.22–1.89

0.42

Time between entry to Japan and diagnosis

 within 2 years

Reference

 more than 2 years, within 5 years

1.62

0.98–2.68

1.69

1.00–2.87

0.05

 more than 5 years, within 10 years

1.62

0.79–3.35

1.50

0.69–3.26

0.31

 10 years or more

0.98

0.55–1.76

0.85

0.43–1.68

0.65

  1. INH isoniazid, RFP rifampicin, CI confidence interval, OR odds ratio